Physician profile
Robert Chudnow
NPI 1831248129
$13,076.28
in general payments reported to CMS, 2019-2025
55 companies · $1,922 in 2025
The $1,922 reported for 2025 was more than what 78% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,020 · 2020: $1,268 · 2021: $1,915 · 2022: $1,988 · 2023: $2,038 · 2024: $1,925 · 2025: $1,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,884 · Education: $1.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,883.74 |
| Education | $1.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $1,490.59 | 2019-2024 | Jornay Pm |
| Ucb, INC. | $1,432.15 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Corium, LLC | $1,085.16 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $752.62 | 2019-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $716.55 | 2019-2025 | Dyanavel Xr, Quillivant |
| Livanova USA, INC. | $665.66 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Jazz Pharmaceuticals INC. | $598.15 | 2019-2025 | Epidiolex |
| Eisai INC. | $571.00 | 2019-2023 | |
| Sk Life Science, INC. | $529.70 | 2021-2025 | Xcopri |
| Neurelis, INC. | $472.49 | 2020-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $411.32 | 2019-2022 | |
| Greenwich Biosciences, INC. | $370.22 | 2019-2021 | |
| Neos Therapeutics, Lp | $310.29 | 2019-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Immedica Pharma US, INC. | $290.07 | 2022-2024 | |
| Acadia Pharmaceuticals INC | $272.78 | 2023-2025 | Daybue |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chudnow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.